针对可逆共价模式的蛋白质-蛋白质相互作用:非氨酸化学物质
Ruchira Basu1, Steven Fletcher1
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
British journal of pharmacology
|March 16, 2026
概括
针对蛋白质-蛋白质相互作用 (PPI) 的可逆共价药物正在超越氨酸. 专注于氨酸和氨酸的新策略为难以达到的药物目标提供了增强的选择性和持续的参与.
科学领域:
- 药用化学 医学化学
- 化学生物学 化学生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白与蛋白相互作用 (PPI) 对细胞功能至关重要,是关键的治疗点.
- 共价药物设计,特别是可逆调制剂,为吸引具有挑战性的PPI目标提供了优势.
- 氨酸是可逆共价药物的常见目标,但局限性需要探索替代化学物质.
研究的目的:
- 审查用于调节PPI的新兴可逆电-核化学物质.
- 突出了氨酸和氨酸作为替代核友性标的潜力,超出了氨酸.
- 探索展示PPI调制新型可逆共价策略的案例研究.
主要方法:
- 对可逆共价药物设计策略的文献综述.
- 分析涉及氨基酸残留的电友-核友反应.
- 检查PPI调制中的案例研究,使用不同的共价化学.
主要成果:
- 可逆共振调制器为PPI目标提供了持续的参与和选择性.
- 氨酸和氨酸代表了对共价药物开发的有希望的替代核友性标.
- 扩展超出基于氨酸的策略,扩大了针对PPI的范围.
结论:
- 针对氨酸和氨酸的新兴可逆共价化学物质具有调节具有挑战性的PPI的巨大潜力.
- 除了氨酸之外,多元化共价药物策略可以克服局限性并打开新的治疗机会.
- 这一审查为开发针对PPI的新型共价疗法提供了基础.
相关概念视频
Drug-Receptor Bonds
5.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
5.2K
Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Covalently Linked Protein Regulators
9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.9K
Covalently Linked Protein Regulators
2.1K
2.1K
Noncovalent Attractions in Biomolecules
65.9K
Noncovalent attractions are associations within and between molecules that influence the shape and structural stability of complexes. These interactions differ from covalent bonding in that they do not involve sharing of electrons.
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
65.9K
Protein Networks
4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K


